LMU-founded antibody reagent supplier ChromoTek has been picked up after raising funding from Bayern Kapital and HTGF in 2010.

QUB spinout ProAxsis has been fully acquired by NetScientific, which previously backed the company’s sole funding round in 2014.

The UC Berkeley spinout has been snapped up by Astellas, two years after the latter took part in its series A round.

Eli Lilly will acquire the WUSTL-linked neurological disease therapy developer in a $135m deal that could top $1.2bn with milestone payments.

Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.

University of Wyoming-backed Momentus is set to merge with SPAC Stable Road Acquisition in a deal that values the space infrastructure company at $1.2bn.

10x Genomics has bought Harvard's genetic sequencing system provider and also revealed it closed its purchase of Stockholm University spinout CartaNA.

CU Boulder's heart disease drug developer MyoKardia has been picked up by BMS after finishing clinical trials on its lead asset.

Satt Erganeo-backed Open Agora offers software to run opinion surveys within enterprise software such as Slack.

The ETH Zurich software security spinout had raised at least $5.2m before it was purchased by Snyk yesterday for an undisclosed sum.